PTC Therapeutics
PTCT
PTCT
164 hedge funds and large institutions have $1.66B invested in PTC Therapeutics in 2018 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 70 increasing their positions, 48 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
164
Holders Change
-16
Holders Change %
-8.89%
% of All Funds
3.66%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.13%
New
19
Increased
70
Reduced
48
Closed
35
Calls
$11.9M
Puts
$15.8M
Net Calls
-$3.89M
Net Calls Change
+$5.75M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$47.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$45.2M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$26.3M |
| 4 |
Renaissance Technologies
New York
|
+$25.4M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$20.2M |
Top Sellers
| 1 |
RI
RTW Investments
New York
|
-$46.4M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$32.9M |
| 3 |
D.E. Shaw & Co
New York
|
-$26.1M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$23.5M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$11.1M |
